Evidence map›Paper›PMID 30325781›Full record

ArticleAIDS (London, England)2019

Do people living with HIV experience greater age advancement than their HIV-negative counterparts?

Davide De Francesco, Ferdinand W Wit, Alexander Bürkle, Sebastian Oehlke, Neeltje A Kootstra, Alan Winston, Claudio Franceschi, Paolo Garagnani, Chiara Pirazzini, Claude Libert and 6 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in AIDS (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05295797 (The Positively Dance Pilot Program), which is not on this map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05295797 naunknown statusnot on this mapstarted 2022, after this paper: background citation

The Positively Dance Pilot Program: Examining the Feasibility of a Peer Research Associate-Led Dance Program for Women Living With HIV

TypeinterventionalSponsorUniversity of British ColumbiaRan2022 to 2023Enrolled30ConditionsHuman Immunodeficiency VirusArmsDance Program
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Exploring HIV provider framings of living and aging with HIV.SSM. Qualitative research in health · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Risk factors for cognitive decline in persons with HIV.Current opinion in infectious diseases · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 5 countries.

Davide De FrancescoInstitute for Global Health, University College London, London, UK.
Ferdinand W WitDepartment of Global Health, Academic Medical Center and Amsterdam Institute for Global Health and Development.
Alexander BürkleMolecular Toxicology Group, University of Konstanz, Konstanz, Germany.
Sebastian OehlkeMolecular Toxicology Group, University of Konstanz, Konstanz, Germany.
Neeltje A KootstraDepartment of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands.
Alan WinstonDivision of Infectious Diseases, Imperial College London, London, UK.
Claudio FranceschiDepartment of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum Universitá di Bologna, Bologna, Italy.
Paolo GaragnaniDepartment of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum Universitá di Bologna, Bologna, Italy.
Chiara PirazziniDepartment of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum Universitá di Bologna, Bologna, Italy.
Claude LibertDepartment of Biomedical Molecular Biology, Ghent University.
Tilman GruneDepartment of Molecular Toxicology, German Institute of Human Nutrition, Nuthetal, Germany.
Daniela WeberDepartment of Molecular Toxicology, German Institute of Human Nutrition, Nuthetal, Germany.
Eugène H J M JansenNational Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Caroline A SabinInstitute for Global Health, University College London, London, UK.
Peter ReissDepartment of Global Health, Academic Medical Center and Amsterdam Institute for Global Health and Development.
the Co-morBidity in Relation to AIDS (COBRA) Collaboration
University of Bologna · ITAcademic Medical Center · NLGerman Institute of Human Nutrition · DEUniversity College London · GBUniversity of Konstanz · DEAmsterdam Institute for Global Health and Development · NLImperial College London · GBNational Institute for Public Health and the Environment · NLVlaams Instituut voor Biotechnologie · BE

Funding

Department of Health NIHR-RP-011-048
6 · The paper itself

Abstract

objectivesDespite successful antiretroviral therapy, people living with HIV (PLWH) may show signs of premature/accentuated aging. We compared established biomarkers of aging in PLWH, appropriately chosen HIV-negative individuals, and blood donors, and explored factors associated with biological age advancement.

designCross-sectional analysis of 134 PLWH on suppressive antiretroviral therapy, 79 lifestyle-comparable HIV-negative controls aged 45 years or older from the Co-morBidity in Relation to AIDS (COBRA) cohort, and 35 age-matched blood donors.

methodsBiological age was estimated using a validated algorithm based on 10 biomarkers. Associations between 'age advancement' (biological minus chronological age) and HIV status/parameters, lifestyle, cytomegalovirus (CMV), hepatitis B (HBV) and hepatitis C virus (HCV) infections were investigated using linear regression.

resultsThe average (95% CI) age advancement was greater in both HIV-positive [13.2 (11.6-14.9) years] and HIV-negative [5.5 (3.8-7.2) years] COBRA participants compared with blood donors [-7.0 (-4.1 to -9.9) years, both P's < 0.001)], but also in HIV-positive compared with HIV-negative participants (P < 0.001). Chronic HBV, higher anti-CMV IgG titer and CD8 T-cell count were each associated with increased age advancement, independently of HIV-status/group. Among HIV-positive participants, age advancement was increased by 3.5 (0.1-6.8) years among those with nadir CD4+ T-cell count less than 200 cells/μl and by 0.1 (0.06-0.2) years for each additional month of exposure to saquinavir.

conclusionBoth treated PLWH and lifestyle-comparable HIV-negative individuals show signs of age advancement compared with blood donors, to which persistent CMV, HBV co-infection and CD8+ T-cell activation may have contributed. Age advancement remained greatest in PLWH and was related to prior immunodeficiency and cumulative saquinavir exposure.

Indexed as

AdultAgedAgingAnti-Retroviral AgentsCross-Sectional StudiesFemaleHIV InfectionsHumansMaleMiddle AgedAnti-Retroviral Agents

Identifiers

PMID30325781
PMCPMC6319574
OpenAlexW2897264072

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.